Clinical Trials Logo

Gastroparesis clinical trials

View clinical trials related to Gastroparesis.

Filter by:

NCT ID: NCT05647135 Not yet recruiting - Trauma Clinical Trials

ImpACt of Very High Protein Content Enteral nUtrition Formulas on Critically Ill MUltipLe trAuma paTiEnts

ACCUMULATE
Start date: December 1, 2022
Phase:
Study type: Observational [Patient Registry]

This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content. - Differences regarding achieving protein and calorie daily targets when using enteral nutrition formulas with different protein content - Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content - Differences regarding body composition when using enteral nutrition formulas with different protein content

NCT ID: NCT05584462 Not yet recruiting - Clinical trials for Diabetic Gastroparesis

Gastroparesis in type2 Diabetic Patient

Start date: November 1, 2023
Phase:
Study type: Observational [Patient Registry]

Gastroparesis is defined by objective delaying of gastric emptying without any evidence of mechanical obstruction. Diabetic gastroparesis is a potential complication that occurs in the setting of poorly controlled diabetes, resulting from dysfunction in the coordination and function of the autonomic nervous system, neurons, and specialized pacemaker cells (interstitial cells of Cajal, ICC) of the stomach and intestine, and the smooth muscle cells of the gastrointestinal tract

NCT ID: NCT05405842 Not yet recruiting - Healthy Clinical Trials

Transauricular Vagal Nerve Stimulation; Functional Dyspepsia and Gastroparesis

AVNS
Start date: May 2023
Phase: N/A
Study type: Interventional

The goal of this study is to establish parameters of gastric myoelectrical activity and heart rate variability in healthy human subjects and compare and contrast them to those with gastroparesis and functional dyspepsia, at baseline and following taVNS.

NCT ID: NCT05314244 Not yet recruiting - Nutrition Clinical Trials

Comparison Between Pylorus-resecting and Preserving Pancreaticoduodenectomy on Delayed Gastric Emptying and Nutrition

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Pylorus preserving pancreaticoduodenectomy has been standard procedure for periampullary benign and malignant disease. Delayed gastric emptying is one of most common complications after the procedure. Recently, pylorus resecting pancreaticoduodenectomy has been actively performed because some studies reported that the procedure can reduce postoperative delayed gastric emptying. However, the level of evidence is low and there was few studies considering nutritional status after pylorus resecting pancreaticoduodenectomy. The purpose of this study is to compare between pylorus-resecting and preserving pancreaticoduodenectomy on postoperative delayed gastric emptying and nutritional status.

NCT ID: NCT04661215 Not yet recruiting - Gastroparesis Clinical Trials

Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms

PSAGS
Start date: July 30, 2024
Phase:
Study type: Observational

The overall objective of this study is to determine if there are pyloric sphincter abnormalities in patients with gastroparesis symptoms and determine how prevalent these abnormalities are using tests to assess the pyloric sphincter - endoluminal functional luminal imaging probe (Endoflip™), water load satiety testing (WLST), and high-resolution cutaneous electrogastrography (HR-EGG) using Gastric Alimetry™ System.

NCT ID: NCT04349670 Not yet recruiting - Gastroparesis Clinical Trials

Safety and Efficacy of GPOEM in the Treatment of Gastroparesis

Start date: June 1, 2020
Phase:
Study type: Observational

The purpose of this study is to assess the clinical efficacy and safety in the treatment of gastroparesis.

NCT ID: NCT03438305 Not yet recruiting - Gastroparesis Clinical Trials

Role of Gastric Ultrasound in Preoperative Assessment of Gastric Volume in Diabetic Patients.

Start date: March 1, 2018
Phase: N/A
Study type: Observational [Patient Registry]

Background :An important risk factor for aspiration is gastric volume, determined in large part by gastric emptying. Unfortunately, measuring gastric volume over time is not easy, and scintigraphy has remained the gold standard technique for many years. Ultrasound has progressively emerged as a useful substitute due to its reduced cost and ease of performance Objectives:Assess whether ultrasonographic measurement of antral cross sectional area (CSA) can be used reliably for the diagnosis of risk stomach which defined by a gastric content volume at risk of clinical consequences for pulmonary aspiration (i.e., presence of solid particles and/or gastric fluid volume >1.5 ml/kg) during the preoperative period in longstanding diabetic patients. Study population : - -Longstanding diabetic patients (group D) - -Non diabetic patients (group N) Study Design : Prospective observational study This study will be conducted at Kasr alainy Hospital; Faculty of Medicine, Cairo University.Patients scheduled for elective operations need General Anesthesia (GA) with endotracheal intubation in theatre of general surgery Preoperative ultrasound to assess gastric residual volume then general anesthesia induction will be Modified Rapid-sequence Induction as follow; Group (D)/(N) : propofol 2-3mg/kg and fentanyl 1 µg/Kg followed by Rocuronium 0.6-1.2 mg/kg. Suction of Gastric Contents by Nasogastric tube (18 french) will be inserted First set of analysis will be comparing preoperative US findings in 2 groups. Second set of analysis will be finding correlation between US findings and suction volume in two groups. Outcome parameters: To assess the residual gastric volume in longstanding diabetic patients compared to non diabetic patients. Sample Size ; was calculated as 48 patients (24) in each group.

NCT ID: NCT02927886 Not yet recruiting - Gastroparesis Clinical Trials

Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective Evaluation of Efficacy

G-POEM
Start date: November 2016
Phase: Phase 3
Study type: Interventional

The objective of the study is to document the clinical efficacy and complications of endoscopic pyloromyotomy in patients with refractory gastroparesis (diabetic, post-operative and idiopathic), compared to Botulinic toxin injection intra-pyloric the results of which are close to the placebo.

NCT ID: NCT02594397 Not yet recruiting - Gastroparesis Clinical Trials

Acupuncture for Diabetic Gastroparalysis: a Randomized Controlled Trial

ADG-RCT
Start date: December 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the different combination of acupoints have different effect on diabetic gastroparalysis.

NCT ID: NCT02264587 Not yet recruiting - Clinical trials for Diabetic Gastroparesis

Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis

MDGP
Start date: October 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effects and mechanism of mosapride citrate on diabetic gastroparesi.